Yu H, Gou X
Curr Issues Mol Biol. 2024; 46(11):11853-11867.
PMID: 39590298
PMC: 11592523.
DOI: 10.3390/cimb46110704.
Gupta S, Mandal S, Banerjee K, Almarshood H, Pushpakumar S, Sen U
Biomolecules. 2024; 14(9).
PMID: 39334931
PMC: 11429536.
DOI: 10.3390/biom14091165.
El Khayari A, Hakam S, Malka G, Rochette L, El Fatimy R
Genes Dis. 2024; 11(6):101174.
PMID: 39224109
PMC: 11367061.
DOI: 10.1016/j.gendis.2023.101174.
Li S, Hu W, Qian L, Sun D
Mol Cell Biochem. 2024; 480(3):1287-1304.
PMID: 39110280
PMC: 11842482.
DOI: 10.1007/s11010-024-05083-0.
Wei Q, Huang J, Livingston M, Wang S, Dong G, Xu H
Kidney Int. 2024; 106(4):640-657.
PMID: 39074555
PMC: 11416318.
DOI: 10.1016/j.kint.2024.06.027.
MicroRNA-30a inhibits cell proliferation in a sepsis-induced acute kidney injury model by targeting the YAP-TEAD complex.
Su J, Wang Y, Xie J, Chen L, Lin X, Lin J
J Intensive Med. 2024; 4(2):231-239.
PMID: 38681790
PMC: 11043643.
DOI: 10.1016/j.jointm.2023.08.004.
The role of non-protein-coding RNAs in ischemic acute kidney injury.
Sabet Sarvestani F, Afshari A, Azarpira N
Front Immunol. 2024; 15:1230742.
PMID: 38390339
PMC: 10881863.
DOI: 10.3389/fimmu.2024.1230742.
Kidney Injury: Focus on Molecular Signaling Pathways.
Liu W, Hu M, Wang L, Mirzaei H
Curr Med Chem. 2024; 31(28):4510-4533.
PMID: 38314680
DOI: 10.2174/0109298673271547231108060805.
MicroRNAs as Biomarkers and Therapeutic Targets for Acute Kidney Injury.
Tsuji K, Nakanoh H, Fukushima K, Kitamura S, Wada J
Diagnostics (Basel). 2023; 13(18).
PMID: 37761260
PMC: 10529274.
DOI: 10.3390/diagnostics13182893.
MicroRNA-668-3p inhibits myoblast proliferation and differentiation by targeting Appl1.
Cao H, Du T, Li C, Wu L, Liu J, Guo Y
BMC Genomics. 2023; 24(1):415.
PMID: 37488537
PMC: 10364376.
DOI: 10.1186/s12864-023-09431-0.
Insights into the mechanisms of triptolide nephrotoxicity through network pharmacology-based analysis and RNA-seq.
Luo Y, Yang S, Wen M, Wang B, Liu J, Li S
Front Plant Sci. 2023; 14:1144583.
PMID: 36959927
PMC: 10027700.
DOI: 10.3389/fpls.2023.1144583.
Effects of contralateral nephrectomy timing and ischemic conditions on kidney fibrosis after unilateral kidney ischemia-reperfusion injury.
Zhang J, Shen R, Lin H, Pan J, Feng X, Lin L
Ren Fail. 2022; 44(1):1568-1584.
PMID: 36154902
PMC: 9543178.
DOI: 10.1080/0886022X.2022.2126790.
Expression of MicroRNAs in Sepsis-Related Organ Dysfunction: A Systematic Review.
Maiese A, Scatena A, Costantino A, Chiti E, Occhipinti C, La Russa R
Int J Mol Sci. 2022; 23(16).
PMID: 36012630
PMC: 9409129.
DOI: 10.3390/ijms23169354.
MicroRNAs in kidney injury and disease.
Mahtal N, Lenoir O, Tinel C, Anglicheau D, Tharaux P
Nat Rev Nephrol. 2022; 18(10):643-662.
PMID: 35974169
DOI: 10.1038/s41581-022-00608-6.
Angiotensin (1-7) protects against renal ischemia-reperfusion injury via regulating expression of NRF2 and microRNAs in Fisher 344 rats.
Zaman A, Banday A
Am J Physiol Renal Physiol. 2022; 323(1):F33-F47.
PMID: 35532070
PMC: 9236878.
DOI: 10.1152/ajprenal.00283.2021.
MicroRNAs in kidney development and disease.
Cerqueira D, Tayeb M, Ho J
JCI Insight. 2022; 7(9).
PMID: 35531954
PMC: 9090243.
DOI: 10.1172/jci.insight.158277.
miR-125b Disrupts Mitochondrial Dynamics via Targeting Mitofusin 1 in Cisplatin-Induced Acute Kidney Injury.
Zhao Y, Lang Y, Zhang M, Liang S, Zhu X, Liu Z
Kidney Dis (Basel). 2022; 8(2):137-147.
PMID: 35527986
PMC: 9021629.
DOI: 10.1159/000520140.
The miR-26a-5p/IL-6 axis alleviates sepsis-induced acute kidney injury by inhibiting renal inflammation.
Chen Y, Zhou X, Wu Y
Ren Fail. 2022; 44(1):551-561.
PMID: 35491874
PMC: 9067948.
DOI: 10.1080/0886022X.2022.2056486.
Epigenetic Regulation in Kidney Transplantation.
Xiang X, Zhu J, Dong G, Dong Z
Front Immunol. 2022; 13:861498.
PMID: 35464484
PMC: 9024296.
DOI: 10.3389/fimmu.2022.861498.
Epigenetics in kidney diseases.
Ding H, Zhang L, Yang Q, Zhang X, Li X
Adv Clin Chem. 2021; 104:233-297.
PMID: 34462056
PMC: 9322755.
DOI: 10.1016/bs.acc.2020.09.005.